Development of strategies to transport CNS drugs across the BBB and biotechnology entrepreneurship
24-27 Oct 2016 Marseille (France)

Program

Monday, October 24, 2016 ›
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
›9:00 (15min)
Welcome, Introduction to the workshop
Michel Khrestchatisky, François Féron/Frederic Chavane, Roisin Owens
›9:15 (45min)
How the blood-brain barrier controls xenobiotics permeability
Pr. Jean-Michel Scherrmann, Faculty of Pharmacy, Paris, France
›10:00 (45min)
Overcoming the Blood-Brain Barrier - The Extra Challenge for CNS Drug Development
Dr. Christopher Untucht, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany
›10:45 (30min)
Coffee break
›11:15 (45min)
The BBB in cerebrovascular dysfunction and seizure disorders
Dr. Nicola Marchi, Institute of Functional Genomics, Montpellier, France
›12:00 (45min)
MicroRNAs in inflammation and ageing at the blood-brain barrier
Pr. Nacho Romero, The Open University, Milton Keynes, UK
›12:45 (1h15)
Lunch
›14:00 (1h)
In vitro models of the BBB: From Animal to Human
Pr. Roméo Cecchelli, Université d’Artois, Lens, France
›15:00 (1h)
CNS drug delivery via Receptor Mediated Transport/Transcytosis
Dr. Michel Khrestchatisky, NICN, CNRS, Marseille, France
›16:00 (30min)
Coffee break
›16:30 (1h)
Innovative conducting polymer solutions for monitoring the blood brain barrier
Dr. Roisin Owens, Center of Microelectronics of Provence, Gardanne
›17:30 (30min)
Closing remarks by students
Session
Speech
Logistics
Break
Tour
Online user: 1